Hydrogen Flush After Cold Storage as a New End ‐Ischemic Ex Vivo Treatment for Liver Grafts Against Ischemia/Reperfusion Injury

In conclusion, HyFACS significantly protected liver grafts from IRI by ameliorating oxidative damage upon reperfusion in the characteristic manner with its route of administration. Given its safety, simplicity, and cost ‐effectiveness, end‐ischemic HyFACS may be a novel pretransplant conditioning for cold‐stored donor organs.

Source: Liver Transplantation - November 8, 2018 Category: Transplant Surgery Authors: Ichiro Tamaki, Koichiro Hata, Yusuke Okamura, Yermek Nigmet, Hirofumi Hirao, Toyonari Kubota, Osamu Inamoto, Jiro Kusakabe, Toru Goto, Tetsuya Tajima, Junichi Yoshikawa, Hirokazu Tanaka, Tatsuaki Tsuruyama, Rene H. Tolba, Shinji Uemoto Tags: Original Article Source Type: research